Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer
Qiuying Tang, Lingyun Wu, Mengyou Xu, Danfang Yan, Jimin Shao, Senxiang Yan
Topics & Concepts
RadioresistanceApoptosisFlow cytometryCancer researchDNA damageIn vivoCell cycleRibonucleotide reductaseMitotic catastropheBiologyCell growthRadiosensitivityChemistryMolecular biologyCell cultureMedicineRadiation therapyProtein subunitBiochemistryDNAGeneticsGeneBiotechnologyInternal medicineMetal-Catalyzed Oxygenation MechanismsCancer, Hypoxia, and MetabolismHeme Oxygenase-1 and Carbon Monoxide